Sustained release oral molsidomine composition for the treatment of atherosclerosis

• 收藏
• 分享

专利权人:

セラベル・ファーマスーティカルズ・リミテッド

发明人:

ゲッツィ，ジョゼフ－ミシェル,ゲッツィ,ジョゼフ-ミシェル

申请号：

JP2007506708

公开号：

JP5117847B2

申请日:

2005.04.01

申请国别(地区):

JP

年份:

2013

代理人:

摘要：

The present invention, which is applicable in the pharmaceutical industry, relates to the use of molsidomine or one of its pharmaceutically acceptable salts, especially in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or reducing the development of atherosclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/